期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

LCT和HPV DNA配合阴道镜在宫颈病变中的临床意义 被引量：6

在线阅读 下载PDF
导出
作者 金海涛 郭晓 刘秀荣 李桂荣 冬国友
机构地区 河北省唐山市妇幼保健院 华北煤炭医学院
出处 《河北医药》 CAS 2009年第5期569-570,共2页 Hebei Medical Journal
基金 唐山市科技计划项目(编号:08130259d)
关键词 LCT HPVDNA 宫颈癌前病变 诊断
分类号 R711.74 [医药卫生—妇产科学] R329.2 [医药卫生—人体解剖和组织胚胎学]
  • 相关文献

参考文献10

  • 1Burd EM. Human papinomavirus and cervical cancer. Clin Micro Rev, 2003, 16:1217.
  • 2Bekkers BL, Massuger LF, Bumen J, et al. Epidemiological clinical aspects of human papillomavirus detection in the prevention of cerical cancer. Rev Med Virol, 2004,14 : 95-105.
  • 3Yuping Wu, Yulong Chen, Longyu Li, et al. Associations of high-risk HPV types and viral load with cervical cancer in China. Journal of Clinical Virology, 2006,35 : 264.
  • 4Jihong Liu, Barbara Rose, Xin Huang, et al. Comparative analysis of characteristics of women with cervical cancer in high-versus low-in 2 cidence regions. Gynecologic Oncology, 2004,94 : 803.
  • 5李荣.TCT检测在宫颈癌筛查中的临床应用[J].江苏医药,2007,33(5):516-517. 被引量：26
  • 6乔友林,章文华,李凌,潘秦镜,杨玲,吴令英,戍寿德,李爱玲,张询,任生达,Belinson J.子宫颈癌筛查方法的横断面比较研究[J].中国医学科学院学报,2002,24(1):50-53. 被引量：351
  • 7Diane Solomon, Ritu Oayar. The Bethesda system for reporting cervicalcytology. Second Edition. New York : Springer-Verlag,2004.76-78.
  • 8Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda system : terminology for reporting result of cervical cytology. JAMA, 2002, 287: 2114.
  • 9Solomon J, Schiffman M, Tarnne R. Comparison of three management strategies for patients with atypical setuamous cells undetermined significance: baseline results from a randomized trial. Natl Cancer Inst, 2001,93: 293- 299.
  • 10潘凌亚.HPV感染与宫颈癌前病变[J].基础医学与临床,2006,26(12):1296-1301. 被引量：26

二级参考文献41

  • 1卫生部肿瘤防治研究办公室.中国恶性肿瘤死亡调查研究[M].北京:人民卫生出版社,1979,1..
  • 2Richart RM. Cervical intraepithelial neoplasia: a review[M]//Sommers SC. Pathology Annual. New York: Appleton- Century- Crofts, 1973:301 -328.
  • 3Koutsky LA, Kiviat NB. C, enital human papillomavirus [M]//K Holmes, P Mardh, P Sparling, et al. Sexually Transmitted Diseases. 3rd ed. New York: McGraw- Hill,1999:347 - 359.
  • 4Wright TC Jr, Denny L, Kuhn L, et al. HPV DNA testing of self- collected vaginal samples compared with cytologic screening to detect cervical cancer[J].JAMA, 2000, 283(1) :81 -86.
  • 5Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia. Using human papillomavirus DNA testing for equivocal papanicolaou results[J]. JAMA, 1999, 281:1605 - 1610.
  • 6zur Hausen H. Papillomaviruses and cancer: From basis studies to clinical application[J]. Nut Rev Cancer, 2002,2:342 - 350.
  • 7Wemess BA, Levine A J, Howley PM. Association of human papillomavirus types 16 and 18 E6 protein with p53 [J]. Science, 1990, 248:76-79.
  • 8Scheffner M, Wemess BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human paillomavirus types 16 and 18promotes the degradation of p53 [J]. Cell, 1990, 63:1129 -1136.
  • 9Klingethutz A J, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of uman papillomavirus type 16[J]. Nature, 1996, 380:79 -82.
  • 10Waggoner S, Cherniky CL. Molecular biology of cervical and vulvar carcinoma [M]// Gershenson DM, McGuire WP, Gore M, et al. Gynecologic Cancer: Controversies in Management. Philadephia: Elsevier Churchill Livingstone,2004: pp65 - 78.

共引文献398

同被引文献47

引证文献6

二级引证文献57

河北医药
2009年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部